Visit COVID-19 resources

[Skip to Content]

Spontaneous improvement in myopic foveoschisis – (Eye 28, 1519 (December 2014))

Dec 11
2014

Spontaneous improvement in myopic foveoschisis Eye 28, 1519 (December 2014). doi:10.1038/eye.2014.203 Authors: Y M Paulus & N M Bressler

  • 11 December 2014

Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment – (Eye 28, 1525 (December 2014))

Dec 11
2014

Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment Eye 28, 1525 (December 2014). doi:10.1038/eye.2014.199 Authors: K Ghasemi Falavarjani & M Modarres

  • 11 December 2014

Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’ – (Eye 28, 1525 (December 2014))

Dec 11
2014

Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’ Eye 28, 1525 (December 2014). doi:10.1038/eye.2014.198 Authors: N V Radke, T K Panakanti, S N Radke & R Ravikoti

  • 11 December 2014

Reply to ‘Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant’ – (Eye 28, 1524 (December 2014))

Dec 11
2014

Reply to ‘Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant’ Eye 28, 1524 (December 2014). doi:10.1038/eye.2014.193 Authors: R Chhabra & S Mahmood

  • 11 December 2014

Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant – (Eye 28, 1523 (December 2014))

Dec 11
2014

Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant Eye 28, 1523 (December 2014). doi:10.1038/eye.2014.192 Authors: K Chalioulias & M M K Muqit

  • 11 December 2014